The Provider Score for the Lung Cancer Score in 17110, Harrisburg, Pennsylvania is 93 when comparing 34,000 ZIP Codes in the United States.
An estimate of 94.64 percent of the residents in 17110 has some form of health insurance. 39.25 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 71.60 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 17110 have VA health insurance. Also, percent of the residents receive TRICARE.
For the 5,672 residents under the age of 18, there is an estimate of 50 pediatricians in a 20-mile radius of 17110. An estimate of 2 geriatricians or physicians who focus on the elderly who can serve the 4,734 residents over the age of 65 years.
In a 20-mile radius, there are 18,243 health care providers accessible to residents in 17110, Harrisburg, Pennsylvania.
Health Scores in 17110, Harrisburg, Pennsylvania
Lung Cancer Score | 78 |
---|---|
People Score | 22 |
Provider Score | 93 |
Hospital Score | 50 |
Travel Score | 70 |
17110 | Harrisburg | Pennsylvania | |
---|---|---|---|
Providers per 10,000 residents | 0.00 | 0.00 | 0.00 |
Pediatricians per 10,000 residents under 18 | 0.00 | 0.00 | 0.00 |
Geriatricians per 10,000 residents over 65 | 0.00 | 0.00 | 0.00 |
## Lung Cancer Score: Harrisburg, PA (ZIP Code 17110) & Primary Care Analysis
Analyzing the landscape of healthcare in Harrisburg, Pennsylvania, specifically within the 17110 ZIP code, requires a multi-faceted approach. A "Lung Cancer Score," while not a formally recognized metric, serves as a conceptual framework to evaluate the accessibility and quality of care relevant to lung cancer prevention, diagnosis, and treatment. This analysis considers primary care availability, physician-to-patient ratios, the adoption of telemedicine, the presence of mental health resources, and overall practice quality. The goal is to provide an informed perspective on the healthcare environment and its potential impact on individuals at risk or affected by lung cancer.
Primary care physicians (PCPs) act as the crucial first line of defense in lung cancer detection and management. Their role encompasses risk assessment, screening recommendations (particularly for high-risk individuals), and initial diagnostic workup. The availability of PCPs, therefore, significantly impacts the early detection and treatment of lung cancer. In Harrisburg (17110), the density of PCPs relative to the population is a critical factor. Data on physician-to-patient ratios, often available through state health departments or professional organizations, provides a baseline understanding. A higher ratio (fewer patients per physician) generally indicates better access. However, this is not the sole determinant of quality.
The quality of primary care extends beyond mere availability. Practices that emphasize preventative care, including robust screening programs and patient education, are particularly valuable. These practices often leverage electronic health records (EHRs) to track patient risk factors (smoking history, family history) and proactively schedule screenings. Evaluating the presence of these elements within primary care practices in 17110 is essential. This includes assessing the integration of smoking cessation programs, which are crucial for reducing lung cancer risk.
Standout practices in the 17110 area may exhibit characteristics that distinguish them. These could include a commitment to patient-centered care, evidenced by positive patient reviews and testimonials. They might also demonstrate a proactive approach to lung cancer screening, utilizing the latest guidelines and technologies. Furthermore, strong partnerships with specialists, such as pulmonologists and oncologists, are vital for ensuring seamless transitions for patients requiring specialized care. Identifying these exemplary practices provides a benchmark for evaluating the overall quality of care within the ZIP code.
Telemedicine has transformed healthcare delivery, particularly in underserved areas. Its impact on lung cancer care is significant. Telemedicine allows for remote consultations with specialists, enabling patients to access expertise regardless of their geographical location. It facilitates follow-up appointments, reducing the burden on patients and improving adherence to treatment plans. In the context of 17110, assessing the adoption of telemedicine by primary care practices and specialist providers is crucial. This includes evaluating the types of telemedicine services offered (e.g., virtual consultations, remote monitoring) and the ease of access for patients.
The emotional and psychological toll of a lung cancer diagnosis is substantial. Mental health resources are therefore an integral component of comprehensive care. Access to mental health professionals, such as therapists and counselors, can significantly improve the quality of life for patients and their families. Evaluating the availability of mental health services within primary care practices and specialist clinics is important. This includes assessing the presence of on-site mental health professionals, referrals to external resources, and the integration of mental health screenings into routine care.
The complexity of lung cancer treatment often necessitates a multidisciplinary approach. This involves collaboration between various specialists, including pulmonologists, oncologists, radiologists, and surgeons. The presence of these specialists within the 17110 area and the degree of collaboration between them are crucial factors. Assessing the availability of specialized equipment, such as advanced imaging technologies, is also important. Hospitals and clinics with state-of-the-art facilities can offer patients the most advanced diagnostic and treatment options.
Furthermore, the integration of research and clinical trials can enhance the quality of care. Practices that participate in research and offer access to clinical trials provide patients with the opportunity to benefit from the latest advancements in lung cancer treatment. Evaluating the involvement of healthcare providers in research and their willingness to offer clinical trial options is a key indicator of quality.
The overall "Lung Cancer Score" for 17110 is not a single number but rather a holistic assessment based on the factors discussed. It is a dynamic evaluation that changes with the evolution of healthcare practices and technologies. The goal is to provide an informed perspective on the healthcare environment and its potential impact on individuals at risk or affected by lung cancer. This understanding empowers individuals to make informed decisions about their care and to advocate for improvements in the healthcare system.
The availability of data, however, is a challenge. Publicly available data on physician-to-patient ratios, telemedicine adoption, and mental health resources may be limited. Information on practice quality often relies on patient reviews and anecdotal evidence. A comprehensive assessment requires gathering data from multiple sources, including healthcare providers, insurance companies, and government agencies.
To visualize and better understand the spatial distribution of healthcare resources in Harrisburg (17110), consider exploring CartoChrome maps. These interactive maps can provide a visual representation of physician locations, hospital facilities, and other relevant healthcare data, allowing for a more in-depth analysis of the healthcare landscape.
Reviews
No reviews yet.
You may also like